阿替唑单抗
医学
贝伐单抗
内科学
肿瘤科
总体生存率
化疗
无容量
癌症
免疫疗法
作者
Mark A. Socinski,Makoto Nishio,Robert M. Jotte,Federico Cappuzzo,F. Orlandi,Daniil Stroyakovskiy,Naoyuki Nogami,Delvys Rodríguez‐Abreu,Denis Moro‐Sibilot,Christian A. Thomas,Fabrice Barlési,Gene Grant Finley,Shengchun Kong,Anthony Lee,Shelley Coleman,Wei Zou,Mark L. McCleland,Geetha Shankar,Martin Reck
标识
DOI：10.1016/j.jtho.2021.07.009
摘要
At the final IMpower150 OS analysis, ACP had numerical, but not statistically significant, OS improvement versus BCP. Updated data with an additional 20 months of follow-up revealed continued OS improvement with ABCP versus BCP in all patients.
科研通智能强力驱动
Strongly Powered by AbleSci AI
PDF的下载单位、IP信息已删除
(2025-6-4)
浮游
无极微光
asdfzxcv
Twonej
Criminology34
专注的问寒
进击的PhD
彭于彦祖
小乔
Mic
Jared
zgrmws
香蕉诗蕊
BowieHuang
smottom
子车茗
niNe3YUE
spc68
竹筏过海
lsl
寻道图强
tuanheqi
ccm
eric888
皖公网安备34019202002308
